VOYA INVESTMENT MANAGEMENT LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$173,461
-36.3%
81,821
+43.1%
0.00%
Q2 2023$272,253
-7.4%
57,196
+10.8%
0.00%
Q1 2023$294,154
-8.8%
51,606
+61.5%
0.00%
Q4 2022$322,487
-55.0%
31,9610.0%0.00%
-100.0%
Q3 2022$716,246
-12.3%
31,961
-3.1%
0.00%
-50.0%
Q2 2022$817,000
-82.1%
32,989
-71.9%
0.00%
-77.8%
Q1 2022$4,559,000
+144.5%
117,595
+269.1%
0.01%
+125.0%
Q4 2021$1,865,000
-86.9%
31,862
-86.7%
0.00%
-85.7%
Q3 2021$14,217,000
-21.7%
239,875
+14.6%
0.03%
-20.0%
Q2 2021$18,164,000
-7.7%
209,287
-12.3%
0.04%
-12.5%
Q1 2021$19,685,000
+7.5%
238,747
+18.6%
0.04%
+8.1%
Q4 2020$18,306,000
+1568.7%
201,318
+633.5%
0.04%
+1750.0%
Q3 2020$1,097,000
+47.4%
27,448
+26.6%
0.00%0.0%
Q2 2020$744,000
+11.0%
21,686
-28.1%
0.00%0.0%
Q1 2020$670,000
+15.9%
30,174
+2.2%
0.00%
+100.0%
Q4 2019$578,000
+71.0%
29,519
+35.8%
0.00%0.0%
Q3 2019$338,000
-31.9%
21,740
-11.0%
0.00%0.0%
Q2 2019$496,000
+12.5%
24,438
-2.7%
0.00%0.0%
Q1 2019$441,000
+37.0%
25,1120.0%0.00%0.0%
Q4 2018$322,000
-3.0%
25,112
+23.4%
0.00%0.0%
Q3 2018$332,000
+43.7%
20,3500.0%0.00%
Q2 2018$231,000
+16.1%
20,3500.0%0.00%
Q1 2018$199,000
+50.8%
20,350
-5.5%
0.00%
Q4 2017$132,000
+55.3%
21,5330.0%0.00%
Q3 2017$85,00021,5330.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders